Two major patient-access victories in one week as government acts on NACDS’ recommendations.
Anticipated PREP Act amendment reflects strong and consistent urging of NACDS.
NACDS President and CEO Steven C. Anderson issued the following statement, upon the release of a U.S. Department of Health and Human Services (HHS) Fact Sheet describing decision-making underway about implications of the May 11, 2023, expiration of the current Public Health Emergency (PHE).
With the U.S. House of Representatives slated to consider legislation related to the pandemic this week, NACDS has an important message: constituents view the importance of pharmacy access as a lesson that must be learned from the past three years.
NACDS details actions needed by Biden Administration and Congress to prevent forced rollback
Sustaining PREP Act pharmacy flexibilities through October 2024 will help keep patients and pharmacies from having to “guess” about issues related to pharmacy access.
CNBC quoted NACDS on its call for the Biden Administration to maintain patients’ access to pharmacies in the effort to keep COVID-19 and flu at bay.
As COVID-19 preparedness enters a new phase, NACDS urges continuity of policies enabling pharmacies to provide key services patients expect and need.
On Tuesday, the National Association of Chain Drug Stores (NACDS) and 93 other patient, public health, and state and national pharmacy groups signed a letter to the Biden Administration urging “formal clarification from the U.S. Department of Health and Human Services (HHS) on potential expiration of pharmacy personnel flexibilities granted during the pandemic.”
Plan reflects NACDS’ comments from 2019 as well as lessons and recommendations from the COVID-19 pandemic.
